Q815K7 AF NFT

2,3-bisphosphoglycerate-independent phosphoglycerate mutase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibqrejwjbhujx6rvm6nlbbmnsqlxq5tgkaqbaf62hq4ubshegzvii/metadata.json
IPFS of structure file: 
bafybeibeycyguvtz474eiysnkljuakuj4c6tof7e4qybhqoazrkikteuyi/AF-Q815K7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x0d8fdA8dacE32AE7cf09A60D975Bb21a26BBD29c
First NFT owner address (bech32): 
genesis1pk8a4rdvuv4w0ncf5cxewkajrgnth55u5takem
Current NFT ID #156819 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
156819
Accession (UniProt):
Q815K7
Name::
2,3-bisphosphoglycerate-independent phosphoglycerate mutase
Experimental Method:
Predicted structure
Sequence source:
Bacillus cereus (strain ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC 15305 / NCIMB 9373 / NCTC 2599 / NRRL B-3711)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q815K7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q815K7|GPMI_BACCR 2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Bacillus cereus (strain ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC 15305 / NCIMB 9373 / NCTC 2599 / NRRL B-3711) OX=226900 GN=gpmI PE=3 SV=1 MRKPTALIILDGFGLREETYGNAVAQAKKPNFDGYWNKFPHTTLTACGEAVGLPEGQMGNSEVGHLNIGAGRIVYQSLTRVNVAIREGEFDKNETFQSAIKSVKEKGTALHLFGLLSDGGVHSHMNHMFALLRLAAKEGVEKVYIHAFLDGRDVGPKTAQSYIDATNEVIKETGVGQFATISGRYYSMDRDKRWDRVEKCYRAMVNGEGPTYKSAEECVEDSYANGIYDEFVLPSVIVNEDNTPVATINDDDAVIFYNFRPDRAIQIARVFTNEDFREFDRGEKVPHIPEFVCMTHFSETVDGYVAFKPMNLDNTLGEVVAQAGLKQLRIAETEKYPHVTFFFSGGREAEFPGEERILINSPKVATYDLKPEMSIYEVTDALVNEIENDKHDVIILNFANCDMVGHSGMMEPTIKAVEATDECLGKVVEAILAKDGVALITADHGNADEELTSEGEPMTAHTTNPVPFIVTKNDVELREDGILGDIAPTMLTLLGVEQPKEMTGKTIIK